loader image

Global Regenerative Trade

Image of globe

Global Regenerative Group (GRG) Announced That the Global Regenerative Academy Has Been Launched

The Global Regenerative Academy is an integral part of the Global Regenerative Group, a
privately-held medical technologies company specializing exclusively on Regenerative Medicine and
stem cell technologies, products, and therapies that significantly enhance the body’s natural healing
Boca Raton, FL, June 06, 2019 –(PR.com)– The Academy focuses on Medical Science and Education.
It is a platform for continuing medical education in the field of Regenerative Medicine with the emphasis
on delivering evidence-based medicine and supporting such research from its members. It will cover all
medical specialties in which therapies fall under the category of “Regenerative.” The Academy will
support entrepreneurial ideas of doctors and researchers through its extensive network of experts over
USA, Europe and Asia. The Academy slogan is “science in practice” meaning – translating scientifically
proven ideas into the clinical practice of doctors and hospitals.
The Global Regenerative Academy believes in optimal patient healthcare. It must be safe, efficient,
accessible, intelligent, and flawlessly technically executed. The Global Regenerative Academy is
committed to providing awareness of evidence-based scientific data to physicians from around the world
and validated learning in the field of clinically applicable Regenerative Medicine therapies.
Mihail Blagoev, President of the Academy says more about his motivation to start this venture: “My long
experience with implementation of regenerative therapies in medical practice granted me the chance to
notice that there is a great dissent in the medical practice and science. I have encountered problems like
lack of evidence of effectiveness about certain therapies, mistakes in clinical trial design, creating false
claims on the product labels, and so on. The origin of these problems is coming from the lack of
evidence-based medicine. The only knowledge that comes to the physicians is from industry sponsored
events with controlled content. Plus, they are short weekend courses that have as main target to sell the
company’s product and persuade the physicians to buy. Patient outcome is not in the center and scientific
evidence is filtered through the lenses of a salesman who wants to close the deal.
“This chaotic environment motivates us to create a single industry free entity involving scientists, doctors,
distributors and entrepreneurs. All these persons will be filtering out the bad science but will also provide
a platform for idea creation. This nurturing environment will stimulate physicians to think creatively and
actually create their own innovations in the field of RegMed. So, we are not only fixing the academia
problem but we are also creating value.”
The Academy will include several major sections – Practical and Theoretical Courses, Discussion tables
and Protocol establishment, Participation in randomized Clinical Trials, Industry-Free Online Social
System, Formalized Programs for Regenerative Medicine education, Publication of Evidence based
Medicine. The Academy will be granting ambassador status to selected members who are going to extend
the Academy executive program in their own part of the world.

The opening event of the Academy will be a three full day Global Regenerative Congress from 6 to 8
September in the capital of Bulgaria – Sofia. The organizers have invited leaders in Regenerative
Medicine from around the world – the US, Europe and Asia. They announce that the congress will be in
two days and will cover 8 panels – Orthopedics, Spine surgery and Pain management, Regenerative and
Aesthetic Gynecology, Regenerative Urology, Hair Restoration, Plastic Surgery, Dermatology and
Wound Care. The participant will have a chance of attending hands-on training on the third day.
Confirmed participation has been received from over 30 countries. Organizers say one of the most
important features of this congress is that it is completely industry free. “We do not want to limit the
scientific content of the congress, as is usually the case when the market interest intervenes. We have
ensured top scientific level from leaders in the field of Regenerative Medicine both researchers and
clinicians who we trust. Participants attendance is CME certified and supports both theoretical and
practical aspects of RegMed,” says Diyan Ganev, General Secretary of the GRC 2019.

Leave a Comment

Your email address will not be published. Required fields are marked *

Vivostat Logo


The uniqueness of the Vivostat® system is a novel patented biotechnological process that enables reliable and reproducible preparation of autologous Fibrin Sealant or Platelet Rich Fibrin (PRF®) without using cryoprecipitation and without the need for a separate thrombin component.


  • The Processor Unit is a non-sterile, reusable, fully automated device that controls the biochemical process.
  • The Processor Unit is used to process the patient’s blood and prepare the Vivostat® Fibrin Sealant or Vivostat PRF® solution.
Vivostat Processor Product
  • The Processor Unit is operated by a single button and a display keeps the nurse informed of the remaining process time and status at all times. No specific installation is required and the large wheelbase makes moving it easy.
  • The Processor Unit can be located in any room or corridor in the operating department. It is most often placed centrally between the operating theatres. This way one Processor Unit can supply a number of operating theatres.
  • In approx.  25 min a concentrated fibrin sealant or PRF® solution is prepared from the patient’s whole blood.
  • The Applicator Unit is a non-sterile, reusable, fully automated device that controls the delivery of the Vivostat® Fibrin Sealant or Vivostat PRF®.
Vivostat Processor Product
  • The large display and integrated microprocessor automatically primes the Spraypen® and informs the surgeon of the remaining volume of fibrin sealant/PRF® throughout the entire process.
  • Different spray modes can be selected depending on the actual procedure or area to be covered. Like the Processor Unit it has a large wheelbase and can easily be moved if required.
  • The disposable set comprises of two parts: A Preparation Kit used to prepare the fibrin sealant or PRF® solution before surgery, and an Application Kit used to activate and apply the fibrin sealant/PRF® solution.


  • Preparation Kit
    The Preparation Kit contains the specially designed Preparation Unit – a sterile disposable device in which the patient’s blood is collected, the biochemical process carried out, and the fibrin sealant or PRF® solution harvested.


  • The Application Kit
    The Application Kit contains the Spraypen®1 and all other items required to prepare the system for the delivery of the fibrin sealant or PRF® solution. The Spraypen® is a sterile, disposable, hand held device which delivers the fibrin sealant or PRF® solution to the tissue. The revolutionary and patented design offers the surgeon unparalleled freedom in controlling the application unlike any other product on the market today.


1Besides the Spraypen®, the Vivostat® system offers different types of applicators, e.g. the Endoscopic Applicator. For a full list of application devices click here

1-2-3 Spray

Three easy steps to prepare Vivostat® Fibrin Sealant or Vivostat PRF®

1. Draw blood from the Patient

Fibrin Prep With Blood Inside

At the time of surgery or up to 24 hours before1, citrate (supplied with the kit) is added to the Preparation Unit. 120 ml of the patient’s own blood is then drawn into the same unit.

2. Process the patient’s blood

Vivostat Processor 800

The Preparation Unit is placed in the Processor Unit. At the touch of a button the process starts; after approx. 25 minutes, an autologous fibrin or PRF® solution is ready for use. No thrombin or bovine components are added to the blood at any time.

3. Load the Applicator Unit and spray

Vivostat Display Applicator

The Fibrin or PRF® solution is easily loaded into the Applicator Unit and applied to the surgical site using one of the unique application devices (e.g. the Spraypen). 1This depends on the type of kit being used. Always consult the “Instructions for Use” supplied with the kit to determine the correct preparation.

The following video illustrates how to prepare and apply autologous fibrin sealant.

Presentation DVD from Vivostat A/S on Vimeo.